HIGHLIGHTS
- who: October and collaborators from the National University of, Hacettepe University, Turkey have published the research work: A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial, in the Journal: (JOURNAL)
- what: Participants will be considered as dropouts if they fail to complete the study for various reasons or use prohibited drugs. Participants have the right to withdraw their consent to participate in the study at any time for any reason. This trial has been approved by the Ethics Committee of Xiyuan Hospital of China . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.